IP Library Assignment 019823/0470
Patent Assignment
Reel/Frame 019823/0470

Assignment of Assignor's Interest

Recorded: 2007-09-13 Pages: 6
Assignors
ANDERSON, MARK B.
Executed: 2007-09-12
WILLARDSEN, ADAM
Executed: 2007-09-12
SUZUKI, KAZUYUKI
Executed: 2007-09-12
Assignee
MYRIAD GENETICS, INC.
320 WAKARA WAY, SALT LAKE CITY, UTAH, 84108
Covered Property (1)
4-Arylamin-Or-4-Heteroarylamino-Quinazolines and Analogs as Activators of Caspases and Inducers of Apoptosis and the Use Thereof
Patent: 7,989,462 →
Application: 11/773,303 →
Publication: US 2008/0004297
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 18, 2007
From: CAI, SUI-XIONG; SIRISOMA, NILANTHA SUDATH; ZHANG, HONG
To: CYTOVIA, INC.
Reel/Frame 019844/0416 →
Assignment of Assignor's Interest Aug 24, 2009
From: MYRIAD GENETICS, INC.
To: MYRIAD PHARMACEUTICALS, INC.
Reel/Frame 023136/0132 →
Change of Name Aug 17, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024849/0119 →
Security Agreement Feb 19, 2014
From: IMMUNE PHARMACEUTICALS INC.; MAXIM PHARMACEUTICALS, INC.; CYTOVIA, INC.
To: MIDCAP FUNDING III, LLC
Reel/Frame 032277/0353 →
Release of Security Interest Aug 5, 2015
From: MIDCAP FINANCIAL TRUST
To: IMMUNE PHARMACEUTICALS, INC.; MAXIM PHARMACEUTICALS, INC.; CYTOVIA, INC.
Reel/Frame 036255/0778 →